BMY vs. KO
BMY (Bristol-Myers Squibb Company) and KO (The Coca-Cola Company) are both stocks. BMY operates in Drug Manufacturers - General (Healthcare), while KO operates in Beverages - Non-Alcoholic (Consumer Defensive). Over the past 10 years, BMY returned 0.92%/yr vs 9.15%/yr for KO. At a 0.36 correlation, their price movements are largely independent.
Performance
BMY vs. KO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMY achieves a 8.54% return, which is significantly lower than KO's 14.47% return. Over the past 10 years, BMY has underperformed KO with an annualized return of 0.92%, while KO has yielded a comparatively higher 9.15% annualized return.
BMY
- 1D
- 1.18%
- 1M
- 1.20%
- YTD
- 8.54%
- 6M
- 12.26%
- 1Y
- 25.69%
- 3Y*
- 0.16%
- 5Y*
- 1.52%
- 10Y*
- 0.92%
KO
- 1D
- 3.46%
- 1M
- 0.32%
- YTD
- 14.47%
- 6M
- 14.32%
- 1Y
- 15.33%
- 3Y*
- 12.95%
- 5Y*
- 10.40%
- 10Y*
- 9.15%
BMY vs. KO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 8.54% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
KO The Coca-Cola Company | 14.47% | 15.60% | 8.88% | -4.43% | 10.61% | 11.37% | 2.47% | 20.60% | 6.77% | 14.38% |
Correlation
The correlation between BMY and KO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 1972 | 0.36 |
Fundamentals
BMY:
$117.03B
KO:
$342.88B
BMY:
$3.57
KO:
$3.18
BMY:
16.06
KO:
25.02
BMY:
0.92
KO:
3.02
BMY:
2.41
KO:
6.96
BMY:
5.83
KO:
10.19
BMY:
$48.48B
KO:
$49.28B
BMY:
$33.33B
KO:
$30.43B
BMY:
$13.34B
KO:
$18.35B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMY vs. KO — Risk / Return Rank
BMY
KO
BMY vs. KO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and The Coca-Cola Company (KO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMY | KO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.17 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.89 | 1.95 | -0.07 |
| Martin ratioReturn relative to average drawdown | 4.15 | 3.82 | +0.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMY | KO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.96 | 0.94 | +0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.65 | -0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.04 | 0.50 | -0.47 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.53 | -0.19 |
Drawdowns
BMY vs. KO - Drawdown Comparison
The maximum BMY drawdown since its inception was -72.03%, which is greater than KO's maximum drawdown of -68.23%. Use the drawdown chart below to compare losses from any high point for BMY and KO.
Loading charts...
Drawdown Indicators
| BMY | KO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.03% | -68.23% | -3.80% |
Max Drawdown (1Y)Largest decline over 1 year | -13.68% | -7.89% | -5.79% |
Max Drawdown (3Y)Largest decline over 3 years | -36.85% | -16.26% | -20.59% |
Max Drawdown (5Y)Largest decline over 5 years | -47.67% | -17.27% | -30.40% |
Max Drawdown (10Y)Largest decline over 10 years | -47.67% | -36.99% | -10.68% |
Current DrawdownCurrent decline from peak | -17.59% | -2.98% | -14.61% |
Average DrawdownAverage peak-to-trough decline | -22.38% | -16.09% | -6.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.21% | 4.03% | +2.18% |
Volatility
BMY vs. KO - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 7.08% compared to The Coca-Cola Company (KO) at 5.91%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than KO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMY | KO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.08% | 5.91% | +1.17% |
Volatility (6M)Calculated over the trailing 6-month period | 17.90% | 12.38% | +5.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.83% | 16.37% | +10.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.02% | 16.10% | +7.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.25% | 18.20% | +7.05% |
Dividends
BMY vs. KO - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.37%, more than KO's 2.59% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.37% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
KO The Coca-Cola Company | 2.59% | 2.92% | 3.12% | 3.12% | 2.77% | 2.84% | 2.99% | 2.89% | 3.29% | 3.23% | 3.38% | 3.07% |
Financials
BMY vs. KO - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and The Coca-Cola Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMY vs. KO - Profitability Comparison
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
KO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported a gross profit of 7.85B and revenue of 12.47B. Therefore, the gross margin over that period was 63.0%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
KO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported an operating income of 4.36B and revenue of 12.47B, resulting in an operating margin of 35.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
KO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported a net income of 3.92B and revenue of 12.47B, resulting in a net margin of 31.5%.
Frequently Asked Questions
BMY and KO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (7.08%) compared to KO (5.91%). In terms of maximum drawdown, BMY dropped -72.03% vs KO's -68.23%.
BMY currently has the higher Sharpe Ratio (0.96 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMY and KO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer